Revenue · 2011–2025
Emergent Biosolutions revenue
$743M−28.8% · FY2025
Emergent Biosolutions (EBS) reported $743M in revenue for fiscal 2025, −28.8% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $743M | −28.8% | Open → |
| FY20242024-12-31 | $1.0B | −0.5% | Open → |
| FY20232023-12-31 | $1.0B | −6.1% | Open → |
| FY20222022-12-31 | $1.1B | −37.0% | Open → |
| FY20212021-12-31 | $1.8B | +12.4% | Open → |
| FY20202020-12-31 | $1.6B | +42.6% | Open → |
| FY20192019-12-31 | $1.1B | +41.4% | Open → |
| FY20182018-12-31 | $782M | +39.5% | Open → |
| FY20172017-12-31 | $561M | +14.8% | Open → |
| FY20162016-12-31 | $489M | −6.5% | Open → |
| FY20152015-12-31 | $523M | +16.1% | Open → |
| FY20142014-12-31 | $450M | +43.9% | Open → |
| FY20132013-12-31 | $313M | +10.9% | Open → |
| FY20122012-12-31 | $282M | +3.1% | Open → |
| FY20112011-12-31 | $273M | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +7.4%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Emergent Biosolutions revenue |url=https://companiesranked.com/en/company/emergent-biosolutions/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Emergent Biosolutions revenue. CompaniesRanked. https://companiesranked.com/en/company/emergent-biosolutions/revenueBibTeX
@misc{companiesranked-en-company-emergent-biosolutions-revenue-2026,
author = {{CompaniesRanked}},
title = {{Emergent Biosolutions revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/emergent-biosolutions/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001367644-26-000015 · February 27, 2026
{{cite web |title=Emergent Biosolutions revenue — 10-K (0001367644-26-000015) |url=https://www.sec.gov/Archives/edgar/data/1367644/000136764426000015/ebs-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.